163 related articles for article (PubMed ID: 24098938)
1. The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion.
Peres J; Prince S
Mol Cancer; 2013 Oct; 12(1):117. PubMed ID: 24098938
[TBL] [Abstract][Full Text] [Related]
2. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
3. The T-box transcription factor, TBX3, is a key substrate of AKT3 in melanomagenesis.
Peres J; Mowla S; Prince S
Oncotarget; 2015 Jan; 6(3):1821-33. PubMed ID: 25595898
[TBL] [Abstract][Full Text] [Related]
4. The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.
Peres J; Kwesi-Maliepaard EM; Rambow F; Larue L; Prince S
Cancer Lett; 2017 Oct; 405():111-119. PubMed ID: 28757416
[TBL] [Abstract][Full Text] [Related]
5. TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
Peres J; Damerell V; Chauhan J; Popovic A; Desprez PY; Galibert MD; Goding CR; Prince S
J Invest Dermatol; 2021 Sep; 141(9):2250-2260.e2. PubMed ID: 33744299
[TBL] [Abstract][Full Text] [Related]
6. The Highly Homologous T-Box Transcription Factors, TBX2 and TBX3, Have Distinct Roles in the Oncogenic Process.
Peres J; Davis E; Mowla S; Bennett DC; Li JA; Wansleben S; Prince S
Genes Cancer; 2010 Mar; 1(3):272-82. PubMed ID: 21779450
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
Boyd SC; Mijatov B; Pupo GM; Tran SL; Gowrishankar K; Shaw HM; Goding CR; Scolyer RA; Mann GJ; Kefford RF; Rizos H; Becker TM
J Invest Dermatol; 2013 May; 133(5):1269-77. PubMed ID: 23190890
[TBL] [Abstract][Full Text] [Related]
8. T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression.
Feng X; Yao W; Zhang Z; Yuan F; Liang L; Zhou J; Liu S; Song J
Oncol Res; 2018 Jul; 26(6):959-966. PubMed ID: 29295731
[TBL] [Abstract][Full Text] [Related]
9. A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.
Du HF; Ou LP; Yang X; Song XD; Fan YR; Tan B; Luo CL; Wu XH
Cell Signal; 2014 Mar; 26(3):580-93. PubMed ID: 24316392
[TBL] [Abstract][Full Text] [Related]
10. Intracellular mechanics and TBX3 expression jointly dictate the spreading mode of melanoma cells in 3D environments.
Higgins G; Higgins F; Peres J; Lang DM; Abdalrahman T; Zaman MH; Prince S; Franz T
Exp Cell Res; 2023 Jul; 428(2):113633. PubMed ID: 37172754
[TBL] [Abstract][Full Text] [Related]
11. The T-Box transcription factor 3 in development and cancer.
Willmer T; Cooper A; Peres J; Omar R; Prince S
Biosci Trends; 2017 Jul; 11(3):254-266. PubMed ID: 28579578
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer.
Amir S; Simion C; Umeh-Garcia M; Krig S; Moss T; Carraway KL; Sweeney C
Br J Cancer; 2016 May; 114(10):1125-34. PubMed ID: 27100732
[TBL] [Abstract][Full Text] [Related]
13. Tbx3 overexpression in human gastric cancer is correlated with advanced tumor stage and nodal status and promotes cancer cell growth and invasion.
Miao ZF; Liu XY; Xu HM; Wang ZN; Zhao TT; Song YX; Xing YN; Huang JY; Zhang JY; Xu H; Xu YY
Virchows Arch; 2016 Nov; 469(5):505-513. PubMed ID: 27553355
[TBL] [Abstract][Full Text] [Related]
14. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
[TBL] [Abstract][Full Text] [Related]
15. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
16. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
17. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration.
Omar R; Cooper A; Maranyane HM; Zerbini L; Prince S
Cancer Lett; 2019 Sep; 459():227-239. PubMed ID: 31202624
[TBL] [Abstract][Full Text] [Related]
18. TBX2 and TBX3: the special value for anticancer drug targets.
Lu J; Li XP; Dong Q; Kung HF; He ML
Biochim Biophys Acta; 2010 Dec; 1806(2):268-74. PubMed ID: 20624445
[TBL] [Abstract][Full Text] [Related]
19. The oncogenic TBX3 is a downstream target and mediator of the TGF-β1 signaling pathway.
Li J; Weinberg MS; Zerbini L; Prince S
Mol Biol Cell; 2013 Nov; 24(22):3569-76. PubMed ID: 24025717
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
